Dr Reddy’s launches anti-asthma tablets in US
November 20th, 2010 - 5:31 pm ICT by IANSMumbai, Nov 20 (IANS) After receiving a regulatory approval from the US Food and Drug Administration (USFDA), pharmaceutical major Dr Reddy’s Laboratories Saturday launched its anti-asthma tablets in the American market.
The approval by the USFDA came after a district court’s decision on the non-infringement of the patent for the tablet. This decision paved the way for the product’s launch.
“On Nov 15, 2010, the US district court of New Jersey granted Dr Reddy’s motion for summary judgment of non-infringement against Astra Zeneca, clearing the way for the launch of the product,” the company said in a regulatory filing.
The company said that soon after the judgment Nov 18, USFDA approved Dr Reddy’s new drug application (ANDA) for Zafirlukast tablets.
“Zafirlukast had total US sales of approximately $50 million for the 12 months ending Aug 31, 2010, according to IMS Health,” the filing further said.
According to the company, the tablets are available in bottles of 60 counts in 10 mg and 20 mg strengths.
- Dr Reddy's to launch lansoprazole capsules in US - Oct 16, 2010
- Orchid gets tentative FDA approval for Alzheimer's drug - Jan 08, 2010
- Bristol Myers Get Approval For Their Diabetes Drug - Nov 07, 2010
- Wockardt gets US nod for Tamsulosin capsules - Sep 29, 2009
- Bhopal gas victims allege unethical drug trials - Feb 24, 2011
- Natco Pharma launches anti-swine flu medicine (Business Capsule) - Sep 18, 2009
- Drug Maker, AstraZeneca, To Reimburse $520 Million - Apr 28, 2010
- DrugMaker AstraZeneka Fee $520M In Non-FDA Approved Marketing - Apr 28, 2010
- US chip maker to set up lab in Bhubaneswar (Business Capsule-Two) - Sep 18, 2009
- Ranbaxy approved to make first generic version of Lipitor - Dec 01, 2011
- US health regulator approves Chennai drug plant - Jun 22, 2011
- Decks cleared for Orchid to market anti-infectives in US - Sep 25, 2009
- Orchid Chemicals signs out-licensing deal with Alvogen - May 05, 2010
- Lupin receives US approval for another drug - Jul 31, 2008
- Ranbaxy settles issue with US health regulator - Dec 21, 2011
Tags: 12 months, 50 million, asthma, astra zeneca, dr reddy, drug application, food and drug, food and drug administration, ims health, infringement, launch, mg strengths, motion for summary judgment, patent, regulatory approval, us district court, us district court of new jersey, us food and drug administration, usfda, zafirlukast